It is generally believed that thermal sensitive liposomes (i.e. vesicles) that contain 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000 (DSPE.2000) maintain a constant permeability to ionic molecules when they are heated to the phase transition temperature of the membrane (Tm). However, DPPC:DSPE.2000 liposome systems have been reported to release encapsulated agent in a "pseudoequilibrium" pattern upon temperature rise, whereby there is a rapid release of encapsulated material followed by no further release. Little effort has been made to determine the mechanism of such release behavior. We aim to explore the potential cause of "pseudoequilibrium" release of DPPC:DSPE.2000 liposome systems in response to temperature rise. Using calcein as a hydrophilic marker, the release pattern of DPPC:DSPE.2000 liposome system at Tm has been carefully determined. The potential mechanism of its release behavior has been further explored using two novel assays (i.e. heating-cooling-reheating assay and incubation assay). Our results show that there is a dramatic enhancement of the permeability of DPPC:DSPE.2000 vesicles to ionized molecules (i.e. calcein) during the initial period of heating to 42 °C. This is believed to result from the opening of the hydrophilic pores at the liquid/solid interface. However, after less than 2 min of incubation at this temperature, no further release of calcein is observed, suggesting that the sizes of pores are reduced, restricting any further movement of calcein molecules. On cooling and reheating the DPPC:DSPE.2000 liposomes to 42 °C, no further release of calcein is observed. The incorporation of MSPC (1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine) extends the release period of calcein from the DPPC:MSPC:DSPE.2000 vesicles to more than 30 min, suggesting that the lysolipid stabilizes the pores in the lipid membrane.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3109/08982104.2013.779702 | DOI Listing |
Chin Med
January 2025
Department of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Zhejiang Chinese Medical University, Hangzhou, China.
Background: Paclitaxel-induced peripheral neuropathy (PIPN) is prevalent among patients receiving paclitaxel chemotherapy, which results in sensory abnormality as well as neuropathic pain. Conventional medications lack effectiveness on PIPN. Clinical trials identified beneficial effects of acupuncture on PIPN among patients receiving chemotherapy.
View Article and Find Full Text PDFJ Eat Disord
January 2025
School of Social Work, Faculty of Social Welfare and Health Sciences, University of Haifa, 3498838, Haifa, Israel.
Objective: The Eating Attitudes Test-26 (EAT-26) is considered the screening instrument of choice to identify eating disorders (ED) symptoms in clinical and community populations, showing a classical three-factor structure. This study assessed whether the factor structure of the EAT-26 in patients with ED was stable at admission and discharge from inpatient treatment.
Methods: We administered the EAT-26 to 207 female adolescents with ED at both admission and discharge.
Inflamm Res
January 2025
Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250014, Shandong, People's Republic of China.
Cardiovascular diseases (CVDs) continue to be a substantial global healthcare burden despite considerable progress in therapies. The inflammatory response during the progression of CVD has attracted considerable attention. Mitochondria serve as the principal energy source for the heart.
View Article and Find Full Text PDFBiomaterials
January 2025
Department of Ultrasound, Southwest Hospital, Army Medical University, Chongqing, 400038, China. Electronic address:
Chemotherapy combined with immunotherapy is a highly promising approach for treating tumors. However, chemotherapeutic drugs often fail to accumulate effectively at the tumor site after systemic administration and they lack sufficient immunogenicity to activate adaptive immunity, making an effective T-cell immune response within the tumor microenvironment difficult to achieve. Here, this work developed drug-loaded nanobubbles (DTX-R837@NBs) that encapsulate the chemotherapy drug docetaxel and the immune adjuvant R837 via a thin-film hydration method.
View Article and Find Full Text PDFAnn Intern Med
January 2025
Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System; Department of Population Health Sciences, Duke University School of Medicine; and Durham Evidence Synthesis Program, Durham Veterans Affairs Health Care System, Durham, North Carolina (J.M.G.).
Background: Postdischarge contacts (PDCs) after hospitalization are common practice, but their effectiveness in reducing use of acute care after discharge remains unclear.
Purpose: To assess the effects of PDC on 30-day emergency department (ED) visits, 30-day hospital readmissions, and patient satisfaction.
Data Sources: MEDLINE, Embase, and CINAHL searched from 2012 to 25 May 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!